17β-hydroxysteroid dehydrogenase type 1 and 2 expression in the human fetus

Junji Takeyama, Takashi Suzuki, Gen Hirasawa, Yasunari Muramatsu, Hiroshi Nagura, Kazuie Iinuma, Junji Nakamura, Ken Ichi Kimura, Makoto Yoshihama, Nobuhiro Harada, Stefan Andersson, Hironobu Sasano

研究成果: Article査読

37 被引用数 (Scopus)

抄録

The present study investigates the expression patterns of 17βhydroxysteroid dehydrogenase (17βHSD) isozymes in human fetal tissues to understand how estrogenic activity is regulated in the human fetus. Using enzyme assay, high 17βHSD activity was detected in the placenta and liver, and low levels of 17βHSD activity were also present in the gastrointestinal tract and kidney. After Northern blot analysis, we detected the messenger ribonucleic acid for 17βHSD type 1 (17βHSD1) only in the placenta, whereas that for 17βHSD type 2 (17βHSD2) was detected in the placenta, liver, gastrointestinal tract, and urinary tract at 20 gestational weeks. In RT-PCR analysis of the messenger ribonucleic acid transcripts, 17βHSD 1 was predominantly expressed in the placenta, brain, heart, lung, and adrenal, whereas 17βHSD2 expression was predominantly detected in the liver, gastrointestinal tract, and kidney. In addition, we detected 17βHSD2 immunoreactive protein in surface epithelial cells of the stomach, absorptive epithelial cells of the small intestine and colon, hepatocytes of the liver, and interstitial cells surrounding the urinary tubules of the renal medulla. 17βHSD2 in these tissues may be functioning in the prevention of in utero exposure of the fetus to excessive estradiol from the maternal circulation and amniotic fluids.

本文言語English
ページ(範囲)410-416
ページ数7
ジャーナルJournal of Clinical Endocrinology and Metabolism
85
1
DOI
出版ステータスPublished - 2000

ASJC Scopus subject areas

  • 内分泌学、糖尿病および代謝内科学
  • 生化学
  • 内分泌学
  • 臨床生化学
  • 生化学、医学

フィンガープリント

「17β-hydroxysteroid dehydrogenase type 1 and 2 expression in the human fetus」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル